GlassScriptPhysician profile
Crystal Lenee Hurst
NPI 1639549371
$4,388.06
in general payments reported to CMS, 2019-2025
30 companies · $327 in 2025
The $327 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $832 · 2022: $1,067 · 2023: $979 · 2024: $1,183 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,489.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,489.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $582.23 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $528.03 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $508.18 | 2021-2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $465.64 | 2021-2024 | Xarelto |
| Abbott Laboratories | $319.39 | 2021-2025 | Cardiomems, Pressurewire, Esprit |
| Surmodics, INC. | $297.43 | 2022-2025 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Venous Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight |
| Pfizer INC. | $146.71 | 2021-2024 | |
| Boston Scientific Corporation | $145.41 | 2022-2025 | Wolverine Coronary Cutting Balloon, Eluvia, Opticross 35 |
| Astrazeneca Pharmaceuticals LP | $135.81 | 2021-2024 | Farxiga |
| Shockwave Medical, INC | $135.33 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher |
| Inari Medical, INC. | $128.32 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Chiesi USA, INC. | $120.39 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $118.62 | 2021-2022 | |
| Medtronic, INC. | $112.43 | 2021-2024 | Aquamantys(Tm), Resolute Onyx |
| Amgen INC. | $110.62 | 2022-2024 | Repatha |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $97.77 | 2021-2023 | Diamondback Peripheral |
| E.R. Squibb & Sons, L.L.C. | $62.08 | 2023-2024 | Camzyos, Eliquis |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.02 | 2021 | |
| Kestra Medical Technology Services, INC. | $41.04 | 2023-2024 | Assure Wcd |
| Novo Nordisk INC | $39.74 | 2021 | |
| Revance Therapeutics, INC. | $35.98 | 2024 | Daxxify |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.02 | 2023-2024 | Jardiance |
| Scpharmaceuticals INC. | $25.97 | 2024 | |
| Cardiva Medical, INC. | $24.73 | 2024 | Cardiva Vascade 6/7f Vcs |
| Janssen Scientific Affairs, LLC | $24.37 | 2023 | Xarelto |
| Cvrx, INC. | $23.46 | 2023 | Barostim Neo System |
| Abiomed | $20.15 | 2025 | |
| Biotronik INC. | $20.05 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $19.74 | 2024 | |
| Terumo Medical Corporation | $17.40 | 2023 | Optitorque, Glidewire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Hurst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.